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Theoretical biology encompasses a broad range of biological disciplines ranging
from mathematical biology and biomathematics to philosophy of biology. Adopting
a broad definition of "biology", Theoretical Biology and Medical Modelling, an open
access journal, considers original research studies that focus on theoretical ideas and
models associated with developments in biology and medicine.Main text
Theoretical Biology and Medical Modelling (TBioMed), a 10 year old online journal,
has steadily grown since its first launch in late 2003 as an independent journal of
BioMed Central (BMC). Included in PubMed and PubMed Central and indexed by SCI
for an impact factor, the journal has increasingly attracted a broad scientific audience,
who are interested in mathematical modelling studies in biology and medicine [1]. We
are pleased to announce that we have accepted the role of Editors-in-Chief of
TBioMed, from June 2013, on behalf of all scholars in the community. We act as suc-
cessors of Dr. Paul Agutter, a medical expert and mathematical modeller, who has
made a respected effort to cultivate the field, grow TBioMed and let the journal be rec-
ognized across the world.
There have been four notable characteristics of TBioMed which we regard as advan-
tageous for the authors and readers and we aim for these to remain unchanged. First,
as an independent journal of BMC, TBioMed has continuously been an open access
journal. The open access journal can permit all scientists across the world to have un-
restricted and unlimited access to every single study in the field of theoretical biology
and medicine. Instead of printing and selling the journal, the authors pay an article
processing charge, thereby allowing all readers to download via internet and print the
article at free of charge. Second, the online journal has another advantage for submit-
ting authors, in that authors do not to have any limitation on the number of pages or
figures and data that can be included, per article. For instance, the authors can decide
whether a rigorous mathematical proof should be included in the main text or in the on-
line only supporting material. Third, TBioMed makes a difference from other journals, in
fulfilling the scope of the latter half of the title “Medical Modelling”, and attracting med-
ical studies that are useful in applications to diagnosis, treatment and prevention. In fact,
many published studies have been operational and directly applicable to existing medical
problems. Fourth, the length of peer review is kept shorter than those of other journals in© 2013 Nishiura et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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we understand that operational studies cannot wait for months and years to reach publi-
cation, even when the study involves rigorous mathematical and analytical exercises.
In the field of theoretical biology and medicine, publications of new studies have
tended to be restricted to those with an explicit methodological advancement and those
significantly improving our understanding in biology. These types of publications, in
particular, are seen in other good journals that have restricted scopes, such as PLoS
Computational Biology or Journal of Theoretical Biology. Otherwise, original modelling
studies are frequently considered by interdisciplinary journals, that remain to be rather
broad and have very little restriction in the content (e.g. PLoS ONE). In relation to this
point, we believe that TBioMed can beautifully fill its biomedical modelling niche, and
indeed, the scope and standpoint of TBioMed are in line with this notion. We aim to
offer a platform to publish, read and discuss relatively unrestricted studies, at the same
time as having good quality control of the scientific content.
Under the Open Access publishing model, authors need to consider the financial sup-
port available to them to cover the article processing charge for publication in
TBioMed [2]. For authors from developing nations in particular, with evident financial
difficulty, BioMed Central operates an open access waiver fund [3] and authors who
genuinely cannot afford to pay the article processing charge are able to request a dis-
cretionary waiver. Otherwise, authors are asked to promise to cover the charge upon
submission, and in return, we promise to make an effort to justify the cost with aca-
demic merit. To justify the article processing charge, we aim to reach an improved im-
pact factor and other citation metrics.
Presently, the impact factor of TBioMed is low to moderate, i.e., 1.46 in 2012, and
other citation metrics are not substantially high (e.g. Eigenfactor is 0.00182). One of
the most important roles for us during the next few years is to ensure greater impact
and better metrics of the journal. Not only to recover and improve the impact factor,
but we also aim to compete with and replace the aforementioned journals in the same
subject category. We plan to promote special issues on topical subject areas and pub-
lish other special materials including award lectures. Moreover, we aim to contribute to
education among students and early career researchers, and we will also consider a
series of solicited review articles, written by invited leading scholars.
As we prepare to lead the journal, we would like to acknowledge the efforts that have
been made by the founding editor, Dr. Denys Wheatley and former Editor-in-Chief,
Dr. Paul Agutter in establishing the journal. Dr. Wheatley has worked on cell biology
to better understand the mechanism of cancer, and most notably, he has been success-
ful in raising and growing important journals in his professional areas including Cancer
Cell International. Dr. Agutter has worked on a broad range of studies in theoretical
biology, including the aetiology of deep venous thrombosis and chronic venous insuffi-
ciency, allometric scaling of metabolic rate, mechanisms of intracellular transport and
history and philosophy of medicine and biology. We must emphasize that Dr. Agutter
has spent a substantial fraction of his personal time in handling the manuscripts pub-
lished in the journal to date, and we also thank him for his voluntary editing of submit-
ted manuscripts written by authors in non-English speaking countries. Dr. Wheatley
and Dr. Agutter are not only friends but also collaborators [4]. Dr. Ed Rietman, Professor
Rongling Wu and I were put forward by Dr. Agutter as his successors, providing him with
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sonal time. As new Editors-in-Chief, all of us have contributed to the journal in different
subjects [5-7], sharing different expertise and having experienced editorial jobs, as part of
the editorial board of TBioMed. To deal with the broad range of subjects covered by the
journal, new associate editors (who help manage peer-review) and editorial board mem-
bers, who represent different subject areas, have been recruited. Moreover, we feel very
confident in having Drs’ Wheatley and Agutter remain involved with the journal as associ-
ate editors. Splitting editorial responsibility into three, whilst supported by our strong
colleagues on the board, we are taking over with a belief that TBioMed can be further
strengthened and take the lead in its subject category.
We invite all authors in the community to consider TBioMed when submitting your
original studies in the area of theoretical biology and medicine. We adopt a broad def-
inition of "biology" and all original research studies that focus on theoretical ideas and
models associated with developments in biology and medicine are considered. Submis-
sions that are not only technically sound, but contributing to the field by offering either
improved understanding in biology or progress in theory or methods will be highly
welcomed.
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